Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on May 18, 2025
Medicines for Poland: L'Europa si trova di fronte a una scelta cruciale sulla riforma del mercato e dei farmaci
GlobeNewswire
·
May 18, 2025
VARSAVIA, Polonia, May 19, 2025 (GLOBE NEWSWIRE) -- Il dibattito tra gli Stati membri in merito alla riforma farmaceutica dell'UE per garantire farmaci a prezzi accessibili e sostenere la produzione europea è quasi giunto al termine. La strategia punta a …
XRP News: As Ripple’s Price Eyes Breakout, $XRT Surges 150% Launches Liquid Staking On XRPL
GlobeNewswire
·
May 18, 2025
TALLINN, Estonia, May 18, 2025 (GLOBE NEWSWIRE) -- XRT Token Now Trading on BitMart and Xpmarket as XRPL’s Fastest-Growing Launchpad Ecosystem Goes Live As XRP consolidates above $2.3 and bullish momentum builds ahead of a potential Ripple IPO, a …
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
GlobeNewswire
·
May 18, 2025
Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patients with Mild and Moderate-to-Severe Symptoms, and Across Geographic Regions HEOR Analyses of Real-World Data Reveal Disparities in Outcomes In Females and Older Patients with Non- …
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
GlobeNewswire
·
May 18, 2025
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in sorbitol and change in 10MWRT and CMT-FOM …
Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting
GlobeNewswire
·
May 18, 2025
Deep, durable and consistent reductions in TTR were sustained at two years, following a one-time dose of nex-z Clinically meaningful improvements in ATTRv-PN related outcomes observed at 24 months compared to baseline, including in patients who were …
Best Anti-Snoring Device 2025: AirSnore Mouthpiece & Drops Review for Sleep Apnea & Deprivation Relief
GlobeNewswire
·
May 18, 2025
Glasgow, May 18, 2025 (GLOBE NEWSWIRE) -- Introduction Consistent, uninterrupted sleep is critical to maintaining sharp focus, stable mood, and long-term health. Yet millions of adults struggle with nightly snoring or mild obstructive sleep apnea — often …
Best Credit Repair & Score Boost 2025: The Credit People Review For Fast Credit Fix & Financial Improvement
GlobeNewswire
·
May 18, 2025
Salt Lake City, Utah, May 18, 2025 (GLOBE NEWSWIRE) -- Introduction: Credit Score Woes in 2025 …